NanoViricides, Inc.NNVCNYSE
Loading
Year-over-year research & development expense growth
Percentile
P43
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 2.06% |
| 2024 | -14.94% |
| 2023 | 10.50% |
| 2022 | -5.39% |
| 2021 | 30.22% |
| 2020 | -20.71% |
| 2019 | 22.68% |
| 2018 | -12.74% |
| 2017 | 10.00% |
| 2016 | 37.39% |